UK cell therapy start-up agrees AstraZeneca partnership worth up to $2bn

in Portfolio News

Quell Therapeutics is developing cell engineering that aims to treat autoimmune diseases

View the article
Investing in Women Code Logo

We invest in talented innovators. We strongly adhere to the view that diversity, including under-represented groups, strongly adds to success. If you are an entrepreneur seeking investment and a partner who can help you to build your business, we would love to hear from you. Please get in contact with our team.